SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
We’re going down soon, to move to a new Data Center today. We’ll be up ASAP. Sorry. |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/14/22 Modular Medical, Inc. 10-Q 9/30/22 45:2.4M Borer Fin’l Comms, Inc. |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 425K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 20K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 20K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 17K 10: R1 Cover HTML 68K 11: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 99K 12: R3 Condensed Consolidated Balance Sheets (Unaudited) HTML 32K (Parenthetical) 13: R4 Condensed Consolidated Statements of Operations HTML 62K (Unaudited) 14: R5 Condensed Consolidated Statements of Stockholders' HTML 68K Equity (Unaudited) 15: R6 Condensed Consolidated Statements of Cash Flows HTML 78K (Unaudited) 16: R7 The Company and Summary of Significant Accounting HTML 54K Policies 17: R8 Leases HTML 23K 18: R9 Ppp Note HTML 17K 19: R10 Convertible Promissory Notes HTML 25K 20: R11 Stockholders? Equity (Deficit) HTML 31K 21: R12 Stock-Based Compensation HTML 74K 22: R13 Income Taxes HTML 20K 23: R14 Commitments & Contingencies HTML 19K 24: R15 The Company and Summary of Significant Accounting HTML 87K Policies (Policies) 25: R16 The Company and Summary of Significant Accounting HTML 23K Policies (Tables) 26: R17 Leases (Tables) HTML 21K 27: R18 Stockholders? Equity (Deficit) (Tables) HTML 23K 28: R19 Stock-Based Compensation (Tables) HTML 74K 29: R20 The Company and Summary of Significant Accounting HTML 21K Policies (Details) 30: R21 The Company and Summary of Significant Accounting HTML 16K Policies (Details Narrative) 31: R22 Leases (Details) HTML 22K 32: R23 Leases (Details Narrative) HTML 17K 33: R24 Ppp Note (Details Narrative) HTML 16K 34: R25 Convertible Promissory Notes (Details Narrative) HTML 36K 35: R26 Stockholders' Equity (Deficit) (Details) HTML 28K 36: R27 Stockholders? Equity (Deficit) (Details Narrative) HTML 18K 37: R28 Stock-Based Compensation (Details) HTML 26K 38: R29 Stock-Based Compensation (Details 2) HTML 41K 39: R30 Stock-Based Compensation (Details 3) HTML 38K 40: R31 Stock-Based Compensation (Details Narrative) HTML 27K 43: XML IDEA XML File -- Filing Summary XML 75K 41: XML XBRL Instance -- modular_2q23_htm XML 478K 42: EXCEL IDEA Workbook of Financial Reports XLSX 70K 6: EX-101.CAL XBRL Calculations -- modd-20220930_cal XML 81K 7: EX-101.DEF XBRL Definitions -- modd-20220930_def XML 144K 8: EX-101.LAB XBRL Labels -- modd-20220930_lab XML 452K 9: EX-101.PRE XBRL Presentations -- modd-20220930_pre XML 353K 5: EX-101.SCH XBRL Schema -- modd-20220930 XSD 72K 44: JSON XBRL Instance as JSON Data -- MetaLinks 180± 259K 45: ZIP XBRL Zipped Folder -- 0001019056-22-000648-xbrl Zip 119K
Exhibit 31.2
CERTIFICATION
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Paul M. DiPerna, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Modular Medical, Inc. for the period ended September 30, 2022;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; |
(d) | Disclosed in this report any change in the registrant’s internal controls over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) | All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/ Paul M. DiPerna | Date: November 14, 2022 | |
Paul M. DiPerna | ||
Chairman, President, Chief Financial Officer and Treasurer |
C:
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 11/14/22 | |||
For Period end: | 9/30/22 | 4 | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/26/22 Modular Medical, Inc. 8-K:3,5,8,9 7/21/22 12:246K Borer Fin’l Comms, Inc. |